- The trend backdrop is active with a 7-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
KMY
GER
Week ended 07 Aug 2026
Weekly Investor Report
Kimberly-Clark Corporation · Consumer Defensive · Household & Personal Products
Latest close
94.11 EUR
-1.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 7.5% above the Trend Line and sits at 45.7% of its 52-week range. The latest completed week returned -1.4%, after a -4.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 53/100.
Setup score
52
out of 100
Latest Close
94.11 EUR
7 Aug 2026
1W Return
-1.4%
latest completed week
4W Return
-4.3%
short-term follow-through
12W Return
16.1%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
3.2x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.4%
Latest completed week; four-week move -4.3%.
Indicator stack
32/71
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
53/100
11 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 7.5% above the Trend Line and sits at 45.7% of its 52-week range. The latest completed week returned -1.4%, after a -4.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6712-week average 0.29
12-week confirmation
Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.67Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.3% over four weeks, 16.1% over 12 weeks, and -14.8% over one year. The current trend has remained active for 7 consecutive weeks.
Performance by holding period
Active trend streak7 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.19Latest activity-pressure read.
Pressure change-6.1%Four-week change in activity pressure.
Leadership-3.93Latest relative-leadership reading.
RS change-198.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength29/100Blend of value, momentum, and quality. Underlying universe rank 72; rank 1 is best.
Value31/100Relative valuation strength. Underlying universe rank 70; rank 1 is best.
Quality83/100Profitability and accounting quality. Underlying universe rank 18; rank 1 is best.
Momentum22/100Medium-term price momentum. Underlying universe rank 79; rank 1 is best.
Growth10/100Revenue and earnings growth. Underlying universe rank 91; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework64/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 14.8x Price divided by trailing earnings.
- Price / sales
- 1.9x Market value relative to trailing revenue.
- EV / EBITDA
- 11.8x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 4.8% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 35.9% Gross profit retained from each unit of revenue.
- Operating margin
- 14.9% Operating profit retained from revenue.
- Free-cash-flow margin
- 11.1% Free cash flow generated from revenue.
- Return on invested capital
- 22.2% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -2.1% Latest one-year revenue growth.
- EPS growth
- -20.6% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -34.8% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 4.7% Cash dividends relative to market value.
- Buyback yield
- 0.2% Net share repurchases relative to market value.
- Shareholder yield
- 4.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 2.0x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment53/100
Weighted news tone is neutral across 11 relevant articles.
1 positive · 8 neutral · 2 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-15.8%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+8.1%Week of 26 Jun.
Worst week-3.6%Week of 6 Mar.
Latest week-1.4%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks0
Modest losses13
Sharp losses0
Recent vol3.4%13-week weekly-return volatility.
Base vol3.2%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew2.2% / -2.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDE Consumer Defensive
4-week rank33 / 38
Group average3.9%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD73.7%positive activity pressure
RS31.6%positive relative leadership
Four-week leaders
IndustryDE Household & Personal Products
4-week rank10 / 11
Group average1.6%
Trend breadth45.5%
Trend45.5%active weekly trend signals
MD90.9%positive activity pressure
RS27.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis59/100Latest 12-week confirmation: trend 7/12, activity pressure 9/12, relative leadership 5/12.
Activity pressure 0.67; No reversal markers Factors41/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 38; Small Cap Core rank 65 SVQF64/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 135.5 of 375 Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment53/100Weighted news tone is neutral across 11 relevant articles.
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 94.11 EUR | -1.4% | 87.58 EUR | 103.8 EUR | 1.19 | -3.93 | 10.1K | On |
| 31 Jul 2026 | 95.42 EUR | -0.7% | 87.16 EUR | 103.8 EUR | 1.24 | -0.48 | 5.5K | On |
| 24 Jul 2026 | 96.08 EUR | 0.2% | 86.78 EUR | 103.9 EUR | 1.22 | 1.88 | 879 | On |
| 17 Jul 2026 | 95.91 EUR | -2.5% | 86.33 EUR | 103.9 EUR | 1.29 | 2.59 | 2.4K | On |
| 10 Jul 2026 | 98.33 EUR | -3.2% | 85.91 EUR | 104.0 EUR | 1.27 | 3.97 | 3.0K | On |
| 3 Jul 2026 | 101.6 EUR | 6.2% | 85.49 EUR | 104.0 EUR | 1.13 | 4.26 | 454 | On |
| 26 Jun 2026 | 95.69 EUR | 8.1% | 85.00 EUR | 104.1 EUR | 0.80 | 2.33 | 570 | On |
| 19 Jun 2026 | 88.48 EUR | 0.5% | 84.80 EUR | 104.2 EUR | 0.43 | -6.77 | 0 | Off |
| 12 Jun 2026 | 88.06 EUR | 4.3% | 84.75 EUR | 104.3 EUR | 0.22 | -6.35 | 60 | Off |
| 5 Jun 2026 | 84.39 EUR | 1.1% | 84.67 EUR | 104.4 EUR | -0.14 | -11.17 | 2.2K | Off |
| 29 May 2026 | 83.50 EUR | -1.2% | 84.73 EUR | 104.6 EUR | -0.03 | -13.83 | 4.3K | Off |
| 22 May 2026 | 84.52 EUR | 4.3% | 85.25 EUR | 104.8 EUR | -0.05 | -12.71 | 8.1K | Off |
| 15 May 2026 | 81.07 EUR | -1.7% | 85.68 EUR | 104.9 EUR | -0.14 | -13.63 | 3.0K | Off |
| 8 May 2026 | 82.44 EUR | 0.6% | 86.29 EUR | 105.1 EUR | 0.02 | -14.18 | 8.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.